The value of bronchial arterial infusionfor advanced non-small cell bronchogenic carcinoma

Abstract

The effect of bronchial arterial infusion (BAI), used in combined therapeutical trials was evaluated in terms of prolonging the survival of inoperable patients with advanced non-small cell lung cancer. A group of 37 cases receiving treatment consisting of BAI and systemic chemotherapy showed better survival periods than 62 cases treated with systemic chemotherapy alone (p<0.01). There was no significant difference in the survival time of 35 cases treated with a combination of BAI, systemic chemotherapy and radiotherapy, and 62 cases treated with a combination of systemic chemotherapy and radiotherapy. Severe side effects were not observed in the BAI groups